New phase II trial investigates CFZ-533 in pediatric and young adults with type 1 diabetes Dec. 13, 2019
DR-10601 shows promise for the treatment of type 2 diabetes and obesity in preclinical models Dec. 10, 2019
Partial clinical hold for pediatric patients in Ipsen's FOP and MO studies of palovarotene Dec. 9, 2019
Arecor reports phase I topline data for ultrarapid-acting insulin product candidate AT-247 Dec. 5, 2019
RSS